The Place of Fluvoxamine in the Treatment of Non-critically ill Patients with COVID-19: A Living Systematic Review and Meta-analysis
Salah Eddine Oussama Kacimi, View ORCID ProfileElona Greca, View ORCID ProfileMohamed Amine Haireche, Ahmed Sallam ElHawary, View ORCID ProfileMounir Ould Setti, View ORCID ProfileRebecca Caruana, Sahar Rizwan, Hidayet Benyettou, Mohammad Yasir Essar, Jaffer Shah, View ORCID ProfileSherief Ghozy
doi: https://doi.org/10.1101/2021.12.19.21268044
Salah Eddine Oussama Kacimi
1Division of Research and Academic Affairs, Larkin Community Hospital, South Miami, USA
2Faculty of Medicine, University of Tlemcen, Tlemcen, Algeria
Elona Greca
1Division of Research and Academic Affairs, Larkin Community Hospital, South Miami, USA
3University of Medicine, Tirana, Albania
Mohamed Amine Haireche
4Building 6822, Waly al Ahd, Holy Makkah 4024-24353, KSA
Ahmed Sallam ElHawary
5Qena Faculty of Medicine, South Valley University, Qena, Egypt
Mounir Ould Setti
6Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
Rebecca Caruana
7Faculty of Medicine and Surgery, University of Malta, Malta
Sahar Rizwan
8Jinnah Sindh Medical University, Karachi, Pakistan
Hidayet Benyettou
1Division of Research and Academic Affairs, Larkin Community Hospital, South Miami, USA
9Department of Cardiology, University-Hospital Center of Tlemcen, Tlemcen, Algeria
Mohammad Yasir Essar
10Kabul University of Medical Sciences, Kanya, Afghanistan
Jaffer Shah
11Medical Research Center, Kateb University, Kabul, Afghanistan
12Drexel University College of Medicine, Philadelphia, PA, US
Sherief Ghozy
13Department of Radiology, Mayo Clinic, Rochester, MN, US
Data Availability
All data produced in the present study are available upon reasonable request to the authors All data produced in the present work are contained in the manuscript All data produced are available online at PubMed
Posted December 21, 2021.
The Place of Fluvoxamine in the Treatment of Non-critically ill Patients with COVID-19: A Living Systematic Review and Meta-analysis
Salah Eddine Oussama Kacimi, Elona Greca, Mohamed Amine Haireche, Ahmed Sallam ElHawary, Mounir Ould Setti, Rebecca Caruana, Sahar Rizwan, Hidayet Benyettou, Mohammad Yasir Essar, Jaffer Shah, Sherief Ghozy
medRxiv 2021.12.19.21268044; doi: https://doi.org/10.1101/2021.12.19.21268044
The Place of Fluvoxamine in the Treatment of Non-critically ill Patients with COVID-19: A Living Systematic Review and Meta-analysis
Salah Eddine Oussama Kacimi, Elona Greca, Mohamed Amine Haireche, Ahmed Sallam ElHawary, Mounir Ould Setti, Rebecca Caruana, Sahar Rizwan, Hidayet Benyettou, Mohammad Yasir Essar, Jaffer Shah, Sherief Ghozy
medRxiv 2021.12.19.21268044; doi: https://doi.org/10.1101/2021.12.19.21268044
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (205)
- Emergency Medicine (372)
- Epidemiology (11633)
- Forensic Medicine (10)
- Gastroenterology (685)
- Genetic and Genomic Medicine (3638)
- Geriatric Medicine (342)
- Health Economics (624)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3393)
- Nursing (193)
- Nutrition (512)
- Oncology (1783)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6031)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (144)